Skip to content

Jagsonpal Pharmaceuticals Limited

  • JAGSNPHARM
  • BSE 507789
  • Healthcare
  • Pharmaceuticals
Rs 216.15−0.58 (−0.27%)
  • As of 13 Nov 2026
  • NSE end-of-day

Over one year the closing price rose 3.04% to Rs 216.15 (13 Nov 2026).

From 14 Nov 2025 to 13 Nov 2026.

Snapshot

Snapshot: The headline figures: market value, P/E, P/B, the 52-week range and the listing date, from the latest close and the latest filed results. The i beside each label says what it means.
  • As of 13 Nov 2026
  • NSE, filings
Market capMarket cap: The market value of all the company's shares: share price times the number of shares in issue. Latest closing share price multiplied by the number of shares in issue, in rupees. Held in rupees; the company page shows crore (1 crore = 10,000,000 rupees). Inputs: closing share price, number of shares in issue. Unit: rupees. Period basis: the latest close. Applies to: All companies. Source: Latest close and shares in issue.
Rs 1,428 Cr
P/EP/E: Share price divided by earnings per share: how many rupees the market price is for each rupee of the company's yearly earnings. Latest closing share price divided by earnings per share over the last twelve months, as a number of times. Inputs: closing share price, earnings per share. Unit: times. Period basis: trailing twelve months. No meaningful value when: Earnings per share over the last twelve months are zero or a loss, or fewer than four quarters are reported. Applies to: All companies. Source: Latest close and trailing-twelve-month earnings per share.
33.77x
P/BP/B: Share price divided by book value per share. Latest closing share price divided by book value per share, as a number of times. Book value per share is shareholders' equity divided by shares in issue. Inputs: closing share price, shareholders' equity, shares in issue. Unit: times. Period basis: latest close and latest balance sheet. No meaningful value when: Shareholders' equity is zero or a deficit. Applies to: All companies. Source: Latest close and the latest balance sheet.
5.93x
ListedListed: The date the company's shares first traded on the exchange. The first trading date recorded by the exchange for the share. Inputs: first trading date. Unit: date. Period basis: a single date. Applies to: All companies. Source: NSE listing record.
1 Mar 2000
52-week range52-week range: The lowest and highest closing prices in the last 52 weeks. The lowest and highest daily closing price over the latest 52 weeks, in rupees per share, adjusted for splits and bonus issues. Inputs: daily closing price. Unit: rupees per share. Period basis: the latest 52 weeks. No meaningful value when: A rights issue, demerger, merger or similar event inside the 52 weeks makes the prices not comparable. Applies to: All companies. Source: Daily NSE prices.
Rs 155.00 – 264.50

What changed

What changed: Filings and results from the report window, newest first, each linked to the original filing. Items after the first four need a free sign-in.
  • As of 15 Nov 2026
  • BSE and NSE filings

7 items in the last 120 days. Latest on 3 Nov 2026: Management stated cost pressure: Price pressures occurred over the last 12 months, especially on APIs. Management stated revenue guidance: Rs 500 crore.

  1. 3 Nov 2026Guidance updateManagement stated cost pressure: Price pressures occurred over the last 12 months, especially on APIs. Management stated revenue guidance: Rs 500 crore.Filing
  2. 28 Oct 2026Financial resultsRevenue changed +6.9% from the prior financial year.No filing link
  3. 28 Oct 2026Guidance updateManagement stated cost pressure: Working capital down 69%. Management stated ebitda guidance: Rs 10 crore. Management stated revenue guidance: USD 1,000 million. Management stated working capital guidance: Working-capital cycle aligned, freeing cash for new opportunities.Filing
  4. 1 Oct 2026AcquisitionThe company completed the acquisition of Group Pharmaceuticals Limited for a 85% stake and consideration of Rs 23.7 crore.Filing

Showing 4 of 7 items on filings and results.

Sign in free to read the rest. A free account, with Google or email. You come back to this section.

Sign in free

About the company

About the company: Classification and registration facts from the exchanges, the reportable segments, and what the company does in its own words where its annual report gives it.
  • As of 13 Nov 2026
  • NSE and BSE listings

Healthcare · Pharmaceuticals · listed 1 Mar 2000 · in BSE Healthcare.

Sector
Healthcare
Industry
Pharmaceuticals
Listed
1 Mar 2000
Face value
Rs 2
Indices
BSE Healthcare
ISIN
INE048B01035
NSE symbol
JAGSNPHARM
BSE code
507789

What the company does is not in our data yet.

A description from the company's own annual report, linked to the page it comes from, will appear here. We do not write one ourselves.

Financials

Financials: Quarterly results and annual statements from the company's filings, in Rs crore. The i beside a label says what it means.
  • Consolidated
  • Rs Cr
  • As of 30 Sept 2026
  • BSE, NSE filings

Sales Rs 96.37 Cr in Q2 FY27 · net profit Rs 12.29 Cr.

StaleSource last updated 30 Sept 2026.

One data point: Quarterly sales was Rs 96.37 Cr (Q2 FY27). One data point: Net profit was Rs 12.29 Cr (Q2 FY27). Only one quarter is on file, so a change against an earlier quarter needs a second one.

Sales Rs crore

QoQ

YoY

Net profit Rs crore

QoQ

YoY

Quarterly results

Quarterly results
Rs Cr, consolidatedQ2 FY27
SalesSales: Revenue from operations in the period. Revenue from operations as filed for the quarter or year shown.Held in rupees; the company page shows crore (1 crore = 10,000,000 rupees). Inputs: revenue from operations. Unit: rupees. Period basis: the quarter or year shown. Applies to: General companies. Not banks, NBFCs or insurers. Source: Quarterly and annual filings.96.37
change QoQQoQ: The change from the previous quarter to the latest quarter, as a percentage of the earlier figure. Latest quarter figure minus previous quarter figure, divided by the previous quarter figure, shown as a percent. Both quarters are on the same statement basis. Inputs: latest quarter figure, previous quarter figure. Unit: percent. Period basis: one quarter apart. No meaningful value when: The earlier figure is zero or a loss. A percent of zero cannot be worked out, and a percent of a loss has no clear meaning. Applies to: All companies. Source: The company's quarterly filings.
change YoYYoY: The change from the same period a year earlier to the latest period, as a percentage of the earlier figure. Latest figure minus the figure for the same quarter a year earlier (or the previous year, for annual figures), divided by the earlier figure, shown as a percent. Inputs: latest figure, figure a year earlier. Unit: percent. Period basis: twelve months apart. No meaningful value when: The earlier figure is zero or a loss. A percent of zero cannot be worked out, and a percent of a loss has no clear meaning. Applies to: All companies. Source: The company's quarterly and annual filings.
Net profitNet profit: What is left of the period's income after all costs, interest and tax. For consolidated figures it is the whole group's profit, including the share that belongs to non-controlling shareholders. Profit after tax as filed for the quarter or year shown. For consolidated figures it includes the share attributable to non-controlling interests; net profit attributable to owners is the owners' share. A negative figure is a loss.Held in rupees; the company page shows crore (1 crore = 10,000,000 rupees). Inputs: profit after tax. Unit: rupees. Period basis: the quarter or year shown. Applies to: All companies. Source: Quarterly and annual filings.12.29
change QoQQoQ: The change from the previous quarter to the latest quarter, as a percentage of the earlier figure. Latest quarter figure minus previous quarter figure, divided by the previous quarter figure, shown as a percent. Both quarters are on the same statement basis. Inputs: latest quarter figure, previous quarter figure. Unit: percent. Period basis: one quarter apart. No meaningful value when: The earlier figure is zero or a loss. A percent of zero cannot be worked out, and a percent of a loss has no clear meaning. Applies to: All companies. Source: The company's quarterly filings.
change YoYYoY: The change from the same period a year earlier to the latest period, as a percentage of the earlier figure. Latest figure minus the figure for the same quarter a year earlier (or the previous year, for annual figures), divided by the earlier figure, shown as a percent. Inputs: latest figure, figure a year earlier. Unit: percent. Period basis: twelve months apart. No meaningful value when: The earlier figure is zero or a loss. A percent of zero cannot be worked out, and a percent of a loss has no clear meaning. Applies to: All companies. Source: The company's quarterly and annual filings.
Net marginNet margin: Net profit as a percentage of revenue. Net profit divided by revenue, both over the last twelve months, shown as a percent. get_financials returns it as a fraction: 0.0888 is 8.88%. Inputs: net profit, revenue. Unit: percent. Period basis: trailing twelve months. No meaningful value when: Revenue is zero. Applies to: All companies. Source: Quarterly and annual filings.12.75%
Operating marginOperating margin: Profit before interest and tax as a percentage of revenue. Profit before tax plus finance costs, divided by revenue, both over the last twelve months, shown as a percent. It keeps other income in. The entry 'Operating margin (excluding other income)' gives a version that leaves it out. Inputs: profit before tax, finance costs, revenue. Unit: percent. Period basis: trailing twelve months. Applies to: General companies. Not banks, NBFCs or insurers. Source: Quarterly and annual filings.17.34%
EPSEPS: Earnings per share: net profit divided by the number of shares. Profit after tax divided by the weighted average number of shares, in rupees per share, as filed for the period shown. Inputs: profit after tax, weighted average number of shares. Unit: rupees per share. Period basis: the quarter or year shown. Applies to: All companies. Source: Quarterly and annual filings.1.86

EPS across a split or bonus

EPS across a split or bonus is not comparable: the share count changed between the periods, so per-share figures before and after it are on different counts. The figures are shown as filed.Split, ratio 5:2, ex-date 8 Jan 2025.

Data notes

No earnings evidence was available to confirm the P/E basis; treat as unverified.
What the data note saysNo earnings evidence was available to confirm the P/E basis; treat as unverified.

Ownership

Ownership: Who held the shares at each quarter end, from the exchange shareholding filings. Each bar adds to 100%.
  • As of 30 Sept 2026
  • BSE shareholding filings

Promoters 68.81% · FIIs 2.14% · DIIs 1.65% · retail and other 27.40% at 30 Sept 2026.

  • PromotersPromoters: The founding or controlling shareholders named in the company's filing. The promoter and promoter-group holding is the percentage of shares in issue they hold, taken from the latest shareholding pattern. Inputs: promoter and promoter-group shares, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing.
  • FIIsFIIs: Foreign institutional investors: overseas funds and institutions holding the shares. The percentage of shares in issue held by foreign portfolio investors, taken from the latest shareholding pattern. Inputs: shares held by foreign portfolio investors, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing.
  • DIIsDIIs: Domestic institutional investors: Indian mutual funds, insurers and similar institutions. The percentage of shares in issue held by mutual funds, insurers, banks and other domestic institutions, taken from the latest shareholding pattern. Inputs: shares held by domestic institutions, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing.
  • Retail and otherRetail and other: Shares held by holders who are not promoters, foreign institutions or domestic institutions. Public-category holding minus foreign portfolio investor holding minus domestic institution holding, as a percent of shares in issue. The page shows it only when the institutional split is published for the quarter. Inputs: public-category holding, foreign portfolio investor holding, domestic institution holding, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. No meaningful value when: The foreign and domestic institutional split is not yet published for the quarter. Applies to: All companies. Source: Exchange shareholding filing.
  • PromotersPromoters: The founding or controlling shareholders named in the company's filing. The promoter and promoter-group holding is the percentage of shares in issue they hold, taken from the latest shareholding pattern. Inputs: promoter and promoter-group shares, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing.68.81%
  • FIIsFIIs: Foreign institutional investors: overseas funds and institutions holding the shares. The percentage of shares in issue held by foreign portfolio investors, taken from the latest shareholding pattern. Inputs: shares held by foreign portfolio investors, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing.2.14%
  • DIIsDIIs: Domestic institutional investors: Indian mutual funds, insurers and similar institutions. The percentage of shares in issue held by mutual funds, insurers, banks and other domestic institutions, taken from the latest shareholding pattern. Inputs: shares held by domestic institutions, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing.1.65%
  • Retail and otherRetail and other: Shares held by holders who are not promoters, foreign institutions or domestic institutions. Public-category holding minus foreign portfolio investor holding minus domestic institution holding, as a percent of shares in issue. The page shows it only when the institutional split is published for the quarter. Inputs: public-category holding, foreign portfolio investor holding, domestic institution holding, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. No meaningful value when: The foreign and domestic institutional split is not yet published for the quarter. Applies to: All companies. Source: Exchange shareholding filing.27.40%
  • Promoter pledgePromoter pledge: The share of the promoters' holding that is pledged or otherwise encumbered. Promoter shares pledged or otherwise encumbered divided by the promoters' total shares, shown as a percent. The base is the promoters' own holding. The same shares as a percent of all shares is a separate figure, promoter pledge as a share of all shares. Inputs: promoter shares pledged or otherwise encumbered, promoters' total shares. Unit: percent of the promoters' holding. Period basis: the latest quarter end. No meaningful value when: The company has no promoter group. Applies to: All companies. Source: Exchange shareholding filing.0.00%

Change in holding

Change from 30 Sept 2025 to 30 Sept 2026, 5 quarters.

Change in holding, 1 year
% of sharesNowA window agoChange
PromotersPromoters: The founding or controlling shareholders named in the company's filing. The promoter and promoter-group holding is the percentage of shares in issue they hold, taken from the latest shareholding pattern. Inputs: promoter and promoter-group shares, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing.68.81%67.54%+1.27 pp
FIIsFIIs: Foreign institutional investors: overseas funds and institutions holding the shares. The percentage of shares in issue held by foreign portfolio investors, taken from the latest shareholding pattern. Inputs: shares held by foreign portfolio investors, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing.2.14%2.12%+0.02 pp
DIIsDIIs: Domestic institutional investors: Indian mutual funds, insurers and similar institutions. The percentage of shares in issue held by mutual funds, insurers, banks and other domestic institutions, taken from the latest shareholding pattern. Inputs: shares held by domestic institutions, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing.1.65%0.09%+1.56 pp
Retail and otherRetail and other: Shares held by holders who are not promoters, foreign institutions or domestic institutions. Public-category holding minus foreign portfolio investor holding minus domestic institution holding, as a percent of shares in issue. The page shows it only when the institutional split is published for the quarter. Inputs: public-category holding, foreign portfolio investor holding, domestic institution holding, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. No meaningful value when: The foreign and domestic institutional split is not yet published for the quarter. Applies to: All companies. Source: Exchange shareholding filing.27.40%30.25%−2.85 pp
Promoter pledgePromoter pledge: The share of the promoters' holding that is pledged or otherwise encumbered. Promoter shares pledged or otherwise encumbered divided by the promoters' total shares, shown as a percent. The base is the promoters' own holding. The same shares as a percent of all shares is a separate figure, promoter pledge as a share of all shares. Inputs: promoter shares pledged or otherwise encumbered, promoters' total shares. Unit: percent of the promoters' holding. Period basis: the latest quarter end. No meaningful value when: The company has no promoter group. Applies to: All companies. Source: Exchange shareholding filing.0.00%0.00%

Promoter holding rose from 67.54% (30 Sept 2025) to 68.81% (30 Sept 2026), up 1.27 percentage points over 5 quarters. DII holding rose from 0.09% (30 Sept 2025) to 1.65% (30 Sept 2026), up 1.56 percentage points over 5 quarters. Retail and other holding fell from 30.25% (30 Sept 2025) to 27.40% (30 Sept 2026), down 2.85 percentage points over 5 quarters.

All figures, every quarter
Shareholding by category
% of sharesJun 22Sept 22Dec 22Mar 23Jun 23Sept 23Dec 23Mar 24Jun 24Sept 24Dec 24Mar 25Jun 25Sept 25Dec 25Mar 26Jun 26Sept 26Change
PromotersPromoters: The founding or controlling shareholders named in the company's filing. The promoter and promoter-group holding is the percentage of shares in issue they hold, taken from the latest shareholding pattern. Inputs: promoter and promoter-group shares, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing.68.71%68.71%68.71%68.71%68.71%68.71%68.48%68.09%68.04%67.97%67.81%67.78%67.65%67.54%67.39%67.89%69.05%68.81%+0.10 pp
FIIsFIIs: Foreign institutional investors: overseas funds and institutions holding the shares. The percentage of shares in issue held by foreign portfolio investors, taken from the latest shareholding pattern. Inputs: shares held by foreign portfolio investors, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing.0.13%0.11%0.10%0.37%0.38%0.53%0.73%1.10%2.30%2.10%2.10%2.18%2.12%2.12%2.44%2.30%2.14%
DIIsDIIs: Domestic institutional investors: Indian mutual funds, insurers and similar institutions. The percentage of shares in issue held by mutual funds, insurers, banks and other domestic institutions, taken from the latest shareholding pattern. Inputs: shares held by domestic institutions, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. Applies to: All companies. Source: Exchange shareholding filing.0.68%0.28%0.77%0.83%0.83%0.83%0.82%0.85%0.85%0.11%0.00%0.00%0.05%0.09%0.15%0.22%0.62%1.65%+0.97 pp
Retail and otherRetail and other: Shares held by holders who are not promoters, foreign institutions or domestic institutions. Public-category holding minus foreign portfolio investor holding minus domestic institution holding, as a percent of shares in issue. The page shows it only when the institutional split is published for the quarter. Inputs: public-category holding, foreign portfolio investor holding, domestic institution holding, shares in issue. Unit: percent of shares in issue. Period basis: the latest quarter end. No meaningful value when: The foreign and domestic institutional split is not yet published for the quarter. Applies to: All companies. Source: Exchange shareholding filing.30.88%30.41%30.36%30.09%30.08%30.17%30.33%30.01%29.62%30.09%30.12%30.12%30.25%30.34%29.45%28.03%27.40%
Promoter pledgePromoter pledge: The share of the promoters' holding that is pledged or otherwise encumbered. Promoter shares pledged or otherwise encumbered divided by the promoters' total shares, shown as a percent. The base is the promoters' own holding. The same shares as a percent of all shares is a separate figure, promoter pledge as a share of all shares. Inputs: promoter shares pledged or otherwise encumbered, promoters' total shares. Unit: percent of the promoters' holding. Period basis: the latest quarter end. No meaningful value when: The company has no promoter group. Applies to: All companies. Source: Exchange shareholding filing.0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Change from 30 Jun 2022 to 30 Sept 2026, 18 quarters.

Dividends and corporate actions

Dividends and corporate actions: Dividends, bonus issues and splits declared in the last five years, from the exchange's corporate-actions filings. Dividend per share is in rupees, by ex-date. A bonus or split changes the share count, so per-share amounts before and after it are not directly comparable.
  • As of 4 Sept 2026
  • BSE corporate actions

4 dividends in the five years shown · latest Rs 4.00 per share, ex-date 4 Sept 2026.

Showing the last five years of corporate actions: 7 from Jun 22 to Sept 26.

Dividend per share went from Rs 5.00 (ex-date 21 Aug 2023) to Rs 4.00 (ex-date 4 Sept 2026) across 4 payments.

Dividend per share Rs per share

Scale starts at Rs 1 per share, not zero, so the differences are easier to see.

Corporate actions
Ex-dateTypeDetailsRs per share
4 Sept 2026DividendFinal Dividend - Rs. - 4.00004.00
4 May 2026BuybackBuy Back of Shares
12 Sept 2025DividendFinal Dividend - Rs. - 2.50002.50
8 Jan 2025SplitStock Split From Rs.5/- to Rs.2/-
6 Sept 2024DividendFinal Dividend - Rs. - 5.00005.00
21 Aug 2023DividendDividend - Rs. - 5.00005.00
8 Jun 2022OtherE.G.M.

Bonus or split

A split (5:2) went ex on 8 Jan 2025. Dividend per share before and after it is on different share counts, so the amounts are not directly comparable. The figures are as declared.

Management and board

Management and board: Who sits on the board and who runs the company, as the company's annual report lists them, and the changes it has filed with the exchanges.
  • As of 29 Jul 2026
  • BSE filings

4 filings under the exchange's board, directorate and management categories in the last twelve months · latest 29 Jul 2026.

Who sits on the board and who runs the company is not in our data yet.

Names, roles, independence, tenure and background, each linked to the annual report page it comes from, will appear here. Until then this section lists the changes the company has filed.

Changes filed with the exchanges

  1. 29 Jul 2026Management and directorsChange in Senior Management personnel of the CompanyFiling
  2. 25 Jun 2026Management and directorsAppointment of Mr. Anil Kumar Matai (DIN: 03122685) as an Additional Director in the category of Non-Executive Independent Director.Filing
  3. 25 Jun 2026Management and directorsAppointment of Mr. Anil Kumar Matai (DIN: 03122865) as an Additional Director in the category of Non-Executive Independent Director.Filing
  4. 18 May 2026Management and directorsResignation of an Independent Director.Filing

Peers

Peers: Companies in the same official BSE industry within a 0.1x to 10x market-cap band, chosen by a fixed rule from the exchange classification. It is a comparison set, not a ranking.
  • As of 13 Nov 2026
  • NSE data and filings

16 companies in the same official industry · market cap Rs 1,428 Cr against a peer median of Rs 8,676 Cr. A comparison set, not a ranking.

Peer comparison
CompanyCMP RsCurrent price: The latest end-of-day closing price of one share. The last closing price recorded by the exchange, in rupees per share. It updates once a day after the close. Inputs: closing price. Unit: rupees per share. Period basis: the latest trading day. Applies to: All companies. Source: Daily NSE prices.Market cap Rs CrMarket cap: The market value of all the company's shares: share price times the number of shares in issue. Latest closing share price multiplied by the number of shares in issue, in rupees. Held in rupees; the company page shows crore (1 crore = 10,000,000 rupees). Inputs: closing share price, number of shares in issue. Unit: rupees. Period basis: the latest close. Applies to: All companies. Source: Latest close and shares in issue.Sales TTM Rs CrSales (trailing twelve months): Revenue over the last four reported quarters added together. The sum of revenue for the last four discrete quarters, in rupees. Held in rupees; the company page shows crore (1 crore = 10,000,000 rupees). Inputs: quarterly revenue. Unit: rupees. Period basis: trailing twelve months. No meaningful value when: Fewer than four reported quarters are available. Applies to: All companies.Profit TTM Rs CrNet profit (trailing twelve months): Profit after tax over the last four reported quarters added together. The sum of profit after tax for the last four discrete quarters, in rupees. Held in rupees; the company page shows crore (1 crore = 10,000,000 rupees). Inputs: quarterly profit after tax. Unit: rupees. Period basis: trailing twelve months. No meaningful value when: Fewer than four reported quarters are available. Applies to: All companies.P/E xP/E: Share price divided by earnings per share: how many rupees the market price is for each rupee of the company's yearly earnings. Latest closing share price divided by earnings per share over the last twelve months, as a number of times. Inputs: closing share price, earnings per share. Unit: times. Period basis: trailing twelve months. No meaningful value when: Earnings per share over the last twelve months are zero or a loss, or fewer than four quarters are reported. Applies to: All companies. Source: Latest close and trailing-twelve-month earnings per share.ROE %ROE: Return on equity: profit the company earned for its owners as a percentage of the equity they have in it. Net profit attributable to owners over the last twelve months divided by average shareholders' equity, shown as a percent. Inputs: net profit attributable to owners, average shareholders' equity. Unit: percent. Period basis: trailing twelve months. No meaningful value when: Shareholders' equity is zero or a deficit, or the balance sheets needed for the average are not filed. Applies to: All companies. Source: Quarterly and annual filings.
CORONA Remedies Limited2,329.714,2481,55920768.82x25.71%
Akums Drugs and Pharmaceuticals Limited741.0511,3464,826364.631.19x11.44%
Viyash Scientific Limited255.3211,2753,713278.847.81x12.87%
Symbiotec Pharmalab Limited1,611.310,353
Blue Jet Healthcare Limited539.3510,2091,096285.333.71x22.89%
Procter & Gamble Health Limited5,8099,6431,491379.925.39x57.72%
Strides Pharma Science Limited1,014.69,3525,21363715.16x21.80%
Aarti Pharmalabs Limited997.959,0492,161256.735.25x12.28%
Sanofi Consumer Healthcare India Limited3,609.48,302979279.729.72x80.40%
Sanofi India Limited3,301.47,5932,235413.320.10x48.02%
Bliss GVS Pharma Limited673.17,1571,074166.544.22x14.37%
Innova Captab Limited1,172.46,7091,86516939.69x16.57%
Sun Pharma Advanced Research Company Limited205.846,6801,9321,635.84.08x291.61%
Concord Biotech Limited5946,2141,170279.444.48x14.75%
FDC Limited372.16,0582,289313.219.34x13.14%
Jagsonpal Pharmaceuticals Limited216.151,42833.77x
Median869.58,6761,898282.533.71x19.18%

Filings and documents

Filings and documents: Every exchange filing in the last twelve months, ten to a page, with a filter by type. Each links to the original document.
  • As of 3 Nov 2026
  • BSE filings

98 filings in twelve months · latest 3 Nov 2026 · most often investor communication (35). Types are grouped from the exchange's own sub-categories.

  1. 3 Nov 2026Investor communicationEarning call transcript for Jagsonpal Pharmaceuticals Limited Q2 FY 27 Earning Conference Call on October 29, 2026 at 2:00 P.MThe company's own statementFiling
  2. 29 Oct 2026Investor communicationAudio Recording of Jagsonpal Pharmaceuticals Limited Q2 FY27 Earnings Conference call on October 29, 2026 at 02:00 P.M.The company's own statementFiling
  3. 29 Oct 2026Investor communicationNewspaper Publication providing extracts of Unaudited Results of Company for the quarter and half ended September 30, 2026.Filing
  4. 28 Oct 2026Results and reportsPress Release for Unaudited Financial Results for the quarter September 30, 2026Filing
  5. 28 Oct 2026Investor communicationPress Release for Unaudited Financial Results for the quarter ended September 30, 2026.Filing
  6. 28 Oct 2026Board and shareholdersOutcome of Board Meeting held on October 28, 2026 along with Unaudited Financial Results(Standalone & Consolidated) for the quarter and half year ended September 30, 2026Filing
  7. 21 Oct 2026Investor communicationIntimation of Analysts/Investors Conference CallFiling
  8. 21 Oct 2026Board and shareholdersJagsonpal Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2026 ,inter alia, to consider and approve Unaudited Financial ....Filing
  9. 9 Oct 2026Compliance and otherCertificate in terms of Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026Filing
  10. 1 Oct 2026Deals, financing and ratingsSubsequent to fulfilment of the Conditions Precedent under the BTA the transactions has been consummated with effect from today i.e. October 01, 2026.Filing
Showing 1–10 of 98Page 1 of 10

Sources and coverage

Sources and coverage: Where each figure comes from, and what this page could not cover, in words.
  • As of 15 Nov 2026
  • DalalOS report

6 filings behind the report · coverage ready.

Not covered

No company-reported operating metrics are available.

Companies are grouped mechanically from the exchange classification and listed by market capitalisation. This is a comparison set, not a ranking or recommendation.

Every value on this page was reported by the company or mechanically calculated from reported values. DalalOS does not estimate missing values or offer a view on whether to trade the security. Research and analysis only, not investment advice. DalalOS is not a SEBI-registered investment adviser.